146 related articles for article (PubMed ID: 10512494)
1. FDA approves pioglitazone for diabetes.
Miller JL
Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
[No Abstract] [Full Text] [Related]
2. Anticipated US approval for rosiglitazone and pioglitazone.
Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
[No Abstract] [Full Text] [Related]
3. Pharmacologic therapy for type 2 diabetes mellitus.
DeFronzo RA
Ann Intern Med; 2000 Jul; 133(1):73-4. PubMed ID: 10877745
[No Abstract] [Full Text] [Related]
4. Rosiglitazone approved for treatment of type 2 diabetes.
Miller JL
Am J Health Syst Pharm; 1999 Jul; 56(13):1292, 1294. PubMed ID: 10683120
[No Abstract] [Full Text] [Related]
5. Improvement of asthma after administration of pioglitazone.
Hashimoto Y; Nakahara K
Diabetes Care; 2002 Feb; 25(2):401. PubMed ID: 11815521
[No Abstract] [Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.
Chilcott J; Wight J; Lloyd Jones M; Tappenden P
Health Technol Assess; 2001; 5(19):1-61. PubMed ID: 11701097
[No Abstract] [Full Text] [Related]
7. From the Food and Drug Administration.
Henney JE
JAMA; 1999 Sep; 282(10):932. PubMed ID: 10485665
[No Abstract] [Full Text] [Related]
8. Warner Lambert/Sankyo diabetes drug nears market.
Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
[No Abstract] [Full Text] [Related]
9. Effects of pioglitazone on diabetes-related outcomes in Hispanic patients.
Jun JK; Gong WC; Mathur R
Am J Health Syst Pharm; 2003 Mar; 60(5):469-73. PubMed ID: 12635453
[No Abstract] [Full Text] [Related]
10. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Gorman C
Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
[No Abstract] [Full Text] [Related]
11. Thiazolidinediones: a comparative review of approved uses.
Sood V; Colleran K; Burge MR
Diabetes Technol Ther; 2000; 2(3):429-40. PubMed ID: 11467345
[TBL] [Abstract][Full Text] [Related]
12. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
13. Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
Kane JP
Diabetes Technol Ther; 2002; 4(2):153-5. PubMed ID: 12079618
[No Abstract] [Full Text] [Related]
14. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone: the future.
Brunetti P
Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244
[No Abstract] [Full Text] [Related]
16. Cardiovascular risk reduction with pioglitazone.
Cardiovasc J S Afr; 2002; 13(4):218. PubMed ID: 12402932
[No Abstract] [Full Text] [Related]
17. Pioglitazone (Actos).
Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011
[No Abstract] [Full Text] [Related]
18. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers.
Hofmann CA; Colca JR
Diabetes Care; 1992 Aug; 15(8):1075-8. PubMed ID: 1505314
[No Abstract] [Full Text] [Related]
19. A new era in type 2 diabetes mellitus treatment?
Laws A
Am J Med; 2001 Jul; 111(1):71-2. PubMed ID: 11448665
[No Abstract] [Full Text] [Related]
20. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
